The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Ipsen; Ipsen; Ipsen; Ipsen
Stock and Other Ownership Interests - Ipsen; Ipsen; Ipsen; Ipsen
Impact of dose reductions on clinical outcomes among patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in oncology clinics in the United States.
 
Paul Cockrum
No Relationships to Disclose
 
Andy Surinach
Consulting or Advisory Role - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
 
George P. Kim
No Relationships to Disclose
 
Daniel Mercer
Consulting or Advisory Role - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
 
Jim M. Koeller
Honoraria - Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; HERON; HERON; HERON; HERON; Merck; Merck; Merck; Merck; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Ipsen; Ipsen; Ipsen; Ipsen; Tocagen; Tocagen; Tocagen; Tocagen
Speakers' Bureau - Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; HERON; HERON; HERON; HERON; Merck; Merck; Merck; Merck; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Celgene; Celgene; Celgene; Celgene
Travel, Accommodations, Expenses - Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Coherus BioSciences; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; Helsinn Healthcare; HERON; HERON; HERON; HERON; Merck; Merck; Merck; Merck; Pfizer; Pfizer; Pfizer; Pfizer; Tocagen; Tocagen; Tocagen; Tocagen
 
Rebecca A. Miksad
Employment - Flatiron Health; Flatiron Health; Flatiron Health; Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Flatiron Health; Flatiron Health; Flatiron Health; Roche; Roche; Roche; Roche
Consulting or Advisory Role - Advanced Medical; Advanced Medical; Advanced Medical; Advanced Medical; Grand Rounds (I); Grand Rounds (I); Grand Rounds (I); Grand Rounds (I); InfiniteMD; InfiniteMD; InfiniteMD; InfiniteMD
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst)
Other Relationship - De Luca Foundation; De Luca Foundation; De Luca Foundation; De Luca Foundation